Peer-Reviewed · Open Access

Annals of Pharmacology and Pharmaceutical Sciences

ISSN 2766-7472
Cover of Annals of Pharmacology and Pharmaceutical Sciences

Aims & Scope

Annals of Pharmacology & Pharmaceutical Sciences (APPS) is a peer-reviewed open access pharmacology and pharmaceutical sciences journal published by Directive Publications. The journal advances scholarship that bridges laboratory, clinic, and population health, publishing rigorous work in clinical pharmacology, pharmacotherapy, drug safety, and the pharmaceutical sciences for researchers, clinicians, pharmacists, regulators, and educators worldwide.

The journal welcomes original research, systematic reviews, case reports, and editorials across pharmacokinetics and pharmacodynamics, cardiovascular pharmacology, pharmacovigilance and adverse drug reactions, medicinal chemistry and drug development, pharmaceutics and formulation, medicine quality assurance, therapeutic drug monitoring, and neuropsychopharmacology. We particularly encourage translational and real-world evidence studies, including guideline-directed therapy, antiplatelet and heart-failure pharmacotherapy, rational drug use, and medicine-quality research relevant to low- and middle-income settings.

Every submission undergoes double-blind peer review in line with COPE principles. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright.

Subject Coverage

Annals of Pharmacology and Pharmaceutical Sciences welcomes original research, reviews, and case reports across the following core areas:

Clinical Pharmacology & Pharmacotherapy
guideline directed medical therapy · rational drug use · pharmacotherapy outcomes research · evidence based prescribing · deprescribing in polypharmacy
Cardiovascular Pharmacology
heart failure pharmacotherapy · ARNi and SGLT2 inhibitors · antiplatelet therapy and aspirin resistance · myocardial infarction drug management · high on-treatment platelet reactivity
Drug Safety & Pharmacovigilance
adverse drug reactions · pharmacovigilance signal detection · post-marketing surveillance · cardiovascular drug safety · spontaneous adverse event reporting
Pharmaceutics & Medicine Quality
drug quality assessment · substandard and falsified medicines · pharmaceutical formulation analysis · uterotonics quality control · good manufacturing practice
Pharmacokinetics & Pharmacodynamics
pharmacokinetic modeling · therapeutic drug monitoring · drug-drug interactions · bioavailability and bioequivalence · dose optimization studies
Neuropsychopharmacology
ADHD pharmacotherapy · non-stimulant treatments · CNS drug response · psychotropic drug safety · neuropharmacology research

Research Topics

Core subject areas published in Annals of Pharmacology and Pharmaceutical Sciences — explore related research across our journals.

Acute Myocardial Infarction Adverse Events Berberine Cardiovascular Safety COVID-19 Heart Failure Hepatic targeting Intestinal distribution Lipid-based formulations Oral bioavailability Postpartum Haemorrhage Quality

Articles

Systematic Review on Acute Myocardial Infarction and Post-Ischemic Heart Failure after COVID-19 Vaccination: Current Evidence On The Effects Of Vaccines

Délio Tiago Martins Malaquias, Joel Eloi Belo Junior, Leocadia Felix de Araújo, Douglas Hipólito Carvalho, Larissa Lauretto, Ana Clara Lobo Ribeiro, Enzo Maruzzo Marques, Felix Adriano Pietroluongo Vidal Tabera, Victoria Geovana Tobias, Samantha Regina Galo Sanches, Felipe Gomes Lacerda, Andre Luiz Vergamini Dias, Ingrid de Mariz Zane, Maria Heloisa Martins Gimenes Gomes, Giovana Casarini Yamashiro, Aline Cristina Couto da Silva, Rubens Rodrigues Tutela, José Antônio do Nascimento Neto, Francisco Rogério de Sousa Mota, Renata Zamboni Lança, Orseli Marques Ferreira Neto, Thiago Augusto Rochetti Bezerra, Carlos Henrique Batista Figueiredo de Mendonça

Quality assessment of oxytocin injection and misoprostol tablets in Côte d'Ivoire and Senegal

F Guiet Mati, C Rerat, R Kuwana, AS Sougou, A Smine, S Dagnoko, D Fall, A Toure, SO Sarr, F Fofana, CS Camara, M Widmer

Editorial Board

Peer review for this journal is governed under COPE principles by an editorial board of 1 member.

View Editorial Board (1) →

Frequently Asked Questions

What topics does Annals of Pharmacology & Pharmaceutical Sciences cover?

APPS covers the full breadth of pharmacology and pharmaceutical sciences, including clinical pharmacology and pharmacotherapy, pharmacokinetics and pharmacodynamics, cardiovascular pharmacology, drug safety and pharmacovigilance, medicinal chemistry and drug development, pharmaceutics and formulation, medicine quality assurance, therapeutic drug monitoring, and neuropsychopharmacology. Both laboratory and real-world clinical studies are welcome.

Who should read and publish in Annals of Pharmacology & Pharmaceutical Sciences?

APPS is intended for pharmacologists, clinical and hospital pharmacists, pharmaceutical scientists, prescribing clinicians, pharmacovigilance and regulatory professionals, and graduate researchers. Authors investigating drug action, drug safety, pharmacotherapy outcomes, or medicine quality - including studies from low- and middle-income settings - are encouraged to submit.

What article types can I submit to APPS?

The journal accepts original research articles, systematic reviews and meta-analyses, narrative and mini-reviews, clinical and pharmacovigilance case reports, short communications, methodology papers, and editorials or commentaries on pharmacology and pharmaceutical sciences.

How does peer review work at Annals of Pharmacology & Pharmaceutical Sciences?

Every manuscript undergoes double-blind peer review, where author and reviewer identities are concealed, conducted in accordance with COPE ethical principles. Submissions are first checked for scope and integrity, then evaluated by subject-matter referees in the relevant pharmacology or pharmaceutical-science subfield.

Is APPS open access, and who holds copyright?

Yes. APPS is fully open access. All accepted articles are published under a Creative Commons Attribution (CC-BY 4.0) licence, and authors retain copyright while permitting reuse with attribution. There are no subscription or paywall barriers to reading the published research.

Are there article-processing charges or waivers for APPS?

As an open access journal, APPS applies an article-processing charge only on acceptance to sustain peer review, production, and permanent hosting. Waivers and discounts are available - authors who need fee support, including those from lower-income settings, are encouraged to request consideration before or during submission.

Related Journals